These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20578983)

  • 1. Cancer therapy by targeting hypoxia-inducible factor-1.
    Li Y; Ye D
    Curr Cancer Drug Targets; 2010 Nov; 10(7):782-96. PubMed ID: 20578983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
    Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
    Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.
    Agani F; Jiang BH
    Curr Cancer Drug Targets; 2013 Mar; 13(3):245-51. PubMed ID: 23297826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress of hypoxia-inducible factor 1 inhibitors against tumors].
    Niu F; Li Y; Lai FF; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):832-6. PubMed ID: 25212028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent agents targeting HIF-1α for cancer therapy.
    Hu Y; Liu J; Huang H
    J Cell Biochem; 2013 Mar; 114(3):498-509. PubMed ID: 22961911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition.
    Choi H; Chun YS; Kim SW; Kim MS; Park JW
    Mol Pharmacol; 2006 Nov; 70(5):1664-71. PubMed ID: 16880289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor.
    Nordgren IK; Tavassoli A
    Chem Soc Rev; 2011 Aug; 40(8):4307-17. PubMed ID: 21483947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia inducible factor-1: a novel target for cancer therapy.
    Belozerov VE; Van Meir EG
    Anticancer Drugs; 2005 Oct; 16(9):901-9. PubMed ID: 16162966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1 signaling in drug resistance to chemotherapy.
    Warfel NA; El-Deiry WS
    Curr Med Chem; 2014; 21(26):3021-8. PubMed ID: 24735366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
    Otrock ZK; Hatoum HA; Awada AH; Ishak RS; Shamseddine AI
    Crit Rev Oncol Hematol; 2009 May; 70(2):93-102. PubMed ID: 19186072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1 (HIF-1).
    Ke Q; Costa M
    Mol Pharmacol; 2006 Nov; 70(5):1469-80. PubMed ID: 16887934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
    Semenza GL
    Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypoxia-inducible factor (HIF) couples immunity with metabolism.
    Halligan DN; Murphy SJ; Taylor CT
    Semin Immunol; 2016 Oct; 28(5):469-477. PubMed ID: 27717536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.
    Vadlapatla RK; Vadlapudi AD; Mitra AK
    Curr Drug Targets; 2013 Jul; 14(8):919-35. PubMed ID: 23701276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypoxia in the hallmarks of human cancer.
    Ruan K; Song G; Ouyang G
    J Cell Biochem; 2009 Aug; 107(6):1053-62. PubMed ID: 19479945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
    Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
    Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?
    López-Lázaro M
    FASEB J; 2006 May; 20(7):828-32. PubMed ID: 16675839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.